Heartflow (HTFL) Cash from Investing Activities (2024 - 2025)
Heartflow (HTFL) posted Cash from Investing Activities of -$235.4 million for Q4 2025, down 18964.13% on a QoQ basis from -$1.2 million in Q3 2025, and down 70816.27% year-over-year from N/an in Q4 2024.
Powered by 
Analysis
Heartflow (HTFL) Cash from Investing Activities (2024 - 2025) Analysis & Trends
Heartflow has reported Cash from Investing Activities for 2 years, with the latest figure at -$235.4 million in Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 70816.27% year-over-year to -$235.4 million in Q4 2025; TTM through Dec 2025 was -$238.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$238.6 million, down 5375.51% from the prior year.
- Cash from Investing Activities was -$235.4 million for Q4 2025 at Heartflow, down from -$1.2 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$332000.0 in Q4 2024, with the low at -$235.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | -115.00 Mn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | -2.02 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -4.00 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -974,000.00 |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | -107.30 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -606,000.00 |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | -6.30 Mn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | 41.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -235.44 Mn |
| Sep 30, 2025 | -1.24 Mn |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | -1.02 Mn |